{"id":"https://openalex.org/W2809950821","doi":"https://doi.org/10.1158/1538-7445.am2018-ct159","title":"Abstract CT159: Olaparib combinations (OLAPCO)for homology-directed DNA repairdefects (HDR)","display_name":"Abstract CT159: Olaparib combinations (OLAPCO)for homology-directed DNA repairdefects (HDR)","publication_year":2018,"publication_date":"2018-07-01","ids":{"openalex":"https://openalex.org/W2809950821","doi":"https://doi.org/10.1158/1538-7445.am2018-ct159","mag":"2809950821"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2018-ct159","doi":"https://doi.org/10.1158/1538-7445.am2018-ct159","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2018-ct159","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5045982804","display_name":"Joseph P. Eder","orcid":"https://orcid.org/0000-0002-7805-0986","observed_orcids":["https://orcid.org/0000-0002-7805-0986"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph P. Eder","raw_affiliation_strings":["1Yale, New Haven, CT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Yale, New Haven, CT;","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045419282","display_name":"Geoffrey Ira Shapiro","orcid":"https://orcid.org/0000-0002-3331-4095","observed_orcids":["https://orcid.org/0000-0002-3331-4095"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Geoffrey I. Shapiro","raw_affiliation_strings":["2Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018655814","display_name":"James M. Cleary","orcid":"https://orcid.org/0000-0001-7213-3951","observed_orcids":["https://orcid.org/0000-0001-7213-3951"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James M. Cleary","raw_affiliation_strings":["2Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002862716","display_name":"Vickie L. Keedy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vickie L. Keedy","raw_affiliation_strings":["3Vanderbilt-Ingram Cancer Center, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Vanderbilt-Ingram Cancer Center, Nashville, TN","institution_ids":["https://openalex.org/I4390039299"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002862716","display_name":"Vickie L. Keedy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vickie L. Keedy","raw_affiliation_strings":["3Vanderbilt-Ingram Cancer Center, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Vanderbilt-Ingram Cancer Center, Nashville, TN","institution_ids":["https://openalex.org/I4390039299"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040738951","display_name":"Ranjit S. Bindra","orcid":"https://orcid.org/0000-0002-3255-0467","observed_orcids":["https://orcid.org/0000-0002-3255-0467"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ranjit Bindra","raw_affiliation_strings":["1Yale, New Haven, CT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Yale, New Haven, CT;","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022014477","display_name":"Brian M. Shuch","orcid":"https://orcid.org/0000-0003-2065-3570","observed_orcids":["https://orcid.org/0000-0003-2065-3570"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian Shuch","raw_affiliation_strings":["1Yale, New Haven, CT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Yale, New Haven, CT;","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012563381","display_name":"Jeffrey Sklar","orcid":"https://orcid.org/0000-0001-5334-6070","observed_orcids":["https://orcid.org/0000-0001-5334-6070"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey Sklar","raw_affiliation_strings":["1Yale, New Haven, CT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Yale, New Haven, CT;","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077582595","display_name":"Khanh T Do","orcid":"https://orcid.org/0000-0002-9411-8899","observed_orcids":["https://orcid.org/0000-0002-9411-8899"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Khanh Do","raw_affiliation_strings":["2Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5030738453","display_name":"Juliane M. Juergensmeier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Juliane Juergensmeier","raw_affiliation_strings":["1Yale, New Haven, CT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Yale, New Haven, CT;","institution_ids":["https://openalex.org/I32971472"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"78","issue":"13_Supplement","first_page":"CT159","last_page":"CT159"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/olaparib","display_name":"olaparib","score":0.9890000224113464},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.8669999837875366},{"id":"https://openalex.org/keywords/azd5363","display_name":"AZD5363","score":0.871999979019165},{"id":"https://openalex.org/keywords/akt-inhibitors","display_name":"AKT inhibitors","score":0.8360000252723694},{"id":"https://openalex.org/keywords/azd1775","display_name":"AZD1775","score":0.9190000295639038},{"id":"https://openalex.org/keywords/wee1-inhibitor","display_name":"WEE1 inhibitor","score":0.7070000171661377},{"id":"https://openalex.org/keywords/azd6738","display_name":"AZD6738","score":0.9860000014305115},{"id":"https://openalex.org/keywords/atr-inhibitors","display_name":"ATR inhibitors","score":0.984000027179718},{"id":"https://openalex.org/keywords/arid1a-mutation","display_name":"ARID1A mutation","score":0.9509999752044678},{"id":"https://openalex.org/keywords/tp53-mutation","display_name":"TP53 mutation","score":0.9860000014305115},{"id":"https://openalex.org/keywords/brca-mutations","display_name":"BRCA mutations","score":0.6959999799728394},{"id":"https://openalex.org/keywords/parp-inhibitor-resistance","display_name":"PARP inhibitor resistance","score":0.4970000088214874}],"concepts":[{"id":"https://openalex.org/C2779962180","wikidata":"https://www.wikidata.org/wiki/Q7083106","display_name":"Olaparib","level":5,"score":0.9908158779144287},{"id":"https://openalex.org/C2779138821","wikidata":"https://www.wikidata.org/wiki/Q7118227","display_name":"PARP inhibitor","level":5,"score":0.7372658848762512},{"id":"https://openalex.org/C2777609662","wikidata":"https://www.wikidata.org/wiki/Q416356","display_name":"PTEN","level":4,"score":0.7037151455879211},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6712653636932373},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.558146595954895},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4621902406215668},{"id":"https://openalex.org/C2778502085","wikidata":"https://www.wikidata.org/wiki/Q7662767","display_name":"Synthetic lethality","level":4,"score":0.42922937870025635},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.41061294078826904},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.37248045206069946},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.36583054065704346},{"id":"https://openalex.org/C134935766","wikidata":"https://www.wikidata.org/wiki/Q210538","display_name":"DNA repair","level":3,"score":0.25651848316192627},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.1832139790058136},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.18126335740089417},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1233227550983429},{"id":"https://openalex.org/C182979987","wikidata":"https://www.wikidata.org/wiki/Q3907241","display_name":"Poly ADP ribose polymerase","level":4,"score":0.10969552397727966},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.09448814392089844},{"id":"https://openalex.org/C82381507","wikidata":"https://www.wikidata.org/wiki/Q416878","display_name":"Polymerase","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2018-ct159","doi":"https://doi.org/10.1158/1538-7445.am2018-ct159","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2018-ct159","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2604303638","https://openalex.org/W7134935615","https://openalex.org/W2994057850","https://openalex.org/W4399667136","https://openalex.org/W2955619322","https://openalex.org/W7221429587","https://openalex.org/W3032225067","https://openalex.org/W4414916399","https://openalex.org/W3203159507","https://openalex.org/W2891966611"],"abstract_inverted_index":{"Abstract":[0],"INTRODUCTION:":[1],"Genetic":[2],"profiling":[3,141,288],"of":[4,33,46,124,204,283,302,373],"tumors":[5,48],"used":[6],"to":[7,65,132,187,213,308,327],"identify":[8,290],"treatment":[9,73],"choices":[10],"for":[11,27,75,90,147,155,168,177,285,377],"cancer":[12,84],"patients":[13,34,77,122,134,284],"focus":[14],"on":[15,107,139,224],"kinase":[16],"mutations":[17,67,85,112,170],"and":[18,82,159,171,179,194,209,305],"well-defined":[19],"translocations;":[20],"multiple":[21],"clinical":[22,104,184,195],"trials":[23],"have":[24,35,39,219],"been":[25,40,220],"initiated":[26],"specific":[28],"kinase-targeted":[29],"agents.":[30],"About":[31],"15-20%":[32],"actionable":[36,278],"mutations.":[37],"HDR":[38,58,92,108,120,178,275],"found":[41],"in":[42,57,63,68,100,121,306,313],"~":[43],"20":[44],"%":[45],"patient":[47,214],"molecularly":[49],"profiled":[50],"at":[51],"the":[52,87,91,281,299,374],"Yale":[53],"Cancer":[54,378,391],"Center.":[55],"Mutations":[56],"related":[59],"genes":[60],"often":[61],"occur":[62],"addition":[64],"other":[66,109],"signaling":[69],"pathways.":[70],"Specific":[71],"targeted":[72,94],"options":[74],"these":[76],"are":[78,86,99,113,186,211,277],"limited,":[79],"as":[80],"breast":[81],"ovarian":[83],"only":[88],"indication":[89],"pathway":[93,157],"PARP":[95],"inhibitors.":[96],"Additional":[97],"drugs":[98],"development,":[101],"but":[102],"few":[103],"studies":[105],"based":[106,138],"than":[110],"BRCA1/2":[111],"open.":[114],"METHODS:":[115],"The":[116,127,183],"OLAPCO":[117],"study":[118],"targets":[119],"irrespective":[123],"tumor":[125,140,189,287],"origin.":[126],"protocol":[128],"includes":[129],"four":[130],"arms":[131],"which":[133],"can":[135,289],"be":[136,328],"enrolled":[137],"results:":[142],"olaparib":[143,149,162,172,180,303],"monotherapy":[144],"(PARP":[145],"inhibitor)":[146,154,167,176],"HDR;":[148],"&":[150,163,173,253,268,272,325],"AZD5363":[151],"(":[152,165],"AKT":[153],"PIK3CA/AKT/PTEN":[156],"dysregulation":[158],"ARID1A":[160],"mutations;":[161],"AZD1775":[164],"wee1":[166],"TP53":[169],"AZD6738":[174],"(ATR":[175],"pre-treated":[181],"patients.":[182],"endpoints":[185],"determine":[188],"overall":[190],"response":[191],"rate":[192,197],"(ORR)":[193],"benefit":[196],"(CBR)":[198],"by":[199],"RECIST":[200],"after":[201],"16":[202],"weeks":[203],"treatment.":[205],"RESULTS:":[206],"Arms":[207],"a":[208,291],"b":[210],"open":[212],"accrual.":[215],"Together,":[216],"34":[217],"pts":[218],"treated,":[221],"12":[222],"remain":[223],"treatment,":[225],"with":[226],"no":[227],"new":[228],"or":[229],">":[230],"Gr":[231],"2":[232],"(CTCAE4)":[233],"treatment-related":[234],"toxicities.":[235],"TABLE":[236],"1Olaparib":[237],"total":[238,256],"=":[239,257,262],"23;":[240],"median":[241,259],"#":[242,260],"cycles=":[243],"2,":[244,263],"range":[245,264],"1-10+":[246],";":[247],"7":[248],"ongoingMutationATMBRCA1IDH1/2FHPALB2CHK2BAP1ARID":[249],"1A#52821212ORR1":[250],"PRCBR10201000TABLE":[251],"2Olaparib":[252],"AZD":[254],"5363":[255],"12;":[258],"cycles":[261],"1-8+;":[265],"5":[266],"ongoingMutationAKT1AKT3AKT2":[267],"PALB2ARID":[269],"1AARID":[270],"1A":[271],"PIK3CAPTEN#321411ORR1CBR10101":[273],"DISCUSSION:":[274],"defects":[276],"mutations,":[279],"increasing":[280],"number":[282],"whom":[286],"therapeutic":[292,300],"option.":[293],"This":[294,317],"exploratory":[295],"trial":[296,318],"is":[297,333],"expanding":[298],"spectrum":[301],"alone":[304],"combination,":[307],"include":[309],"heretofore":[310],"non-canonical":[311],"alterations":[312],"HDR,":[314],"beyond":[315],"BRCA1/2.":[316],"design":[319],"allows":[320],"additional":[321],"molecular":[322],"targets,":[323],"agents":[324],"combinations":[326,364],"rapidly":[329],"evaluated.":[330],"AstraZeneca":[331],"support":[332],"gratefully":[334],"acknowledged.":[335],"Citation":[336],"Format:":[337],"Joseph":[338],"P.":[339],"Eder,":[340],"Geoffrey":[341],"I.":[342],"Shapiro,":[343],"James":[344],"M.":[345],"Cleary,":[346],"Vickie":[347,350],"L.":[348,351],"Keedy,":[349,352],"Ranjit":[353],"Bindra,":[354],"Brian":[355],"Shuch,":[356],"Jeffrey":[357],"Sklar,":[358],"Khanh":[359],"Do,":[360],"Juliane":[361],"Juergensmeier.":[362],"Olaparib":[363],"(OLAPCO)for":[365],"homology-directed":[366],"DNA":[367],"repairdefects":[368],"(HDR)":[369],"[abstract].":[370],"In:":[371],"Proceedings":[372],"American":[375],"Association":[376],"Research":[379],"Annual":[380],"Meeting":[381],"2018;":[382],"2018":[383],"Apr":[384],"14-18;":[385],"Chicago,":[386],"IL.":[387],"Philadelphia":[388],"(PA):":[389],"AACR;":[390],"Res":[392],"2018;78(13":[393],"Suppl):Abstract":[394],"nr":[395],"CT159.":[396]},"counts_by_year":[{"year":2021,"cited_by_count":1}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2018-07-10T00:00:00"}